missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human B3GNT5 (aa 226-341) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (87%), Rat (87%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-53578 (PA5-53578. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
B3GNT5 is a member of the beta-1,3-N-acetylglucosaminyltransferase family. This enzyme is a type II membrane protein. It exhibits strong activity to transfer GlcNAc to glycolipid substrates and is identified as the most likely candidate for lactotriaosylceramide synthase. This enzyme is essential for the expression of Lewis X epitopes on glycolipids.
Specifications
Specifications
| Accession Number | Q9BYG0 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 84002 |
| Name | Human B3GNT5 (aa 226-341) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | B3gnt5; B3GN-T5; beta 1,3 N-acetyglucosaminyltransferase Lc3 synthase; beta-1,3-Gn-T5; beta-1,3-N-acetylglucosaminyltransferase 5; beta-1,3-N-acetylglucosaminyltransferase bGnT-5; beta-1,3-N-acetylglucosaminyltransferase-5; beta3GnT5; beta3Gn-T5; BGnT-5; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase; Lactotriaosylceramide synthase; lc(3)Cer synthase; lc3 synthase; UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
| Common Name | B3GNT5 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction